Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4120 stock hub

TPEX/4120 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4120is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4120

In the news

Latest news · TPEX/4120

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-7.3

P25 -16.2P50 0.3P75 9.8

ROIC-3.6

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4120 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

TWD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	339
Enterprise value	TWD 6.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004120001
Last refreshed	2026-05-10
Market cap	TWD 4B
Price	TWD 46.55
Price currency	TWD
Rev Per Employee	13,554,873.16x
Sector	Healthcare
Sic	2834
Symbol	tpex/4120
Website	https://www.oepgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.05%
EV Earnings	-11.07x
EV/FCF	-13.48x
EV/Sales	1.37x
FCF yield	-11.54%
P/B ratio	0.55x
P/S ratio	0.88x
PE Ratio10 Y	25.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.76%
EBITDA Margin	-3.37%
Gross margin	48.69%
Gross Profit	TWD 2.2B
Gross Profit Growth	8.28%
Gross Profit Growth Q	7.02%
Gross Profit Growth3 Y	3.25%
Gross Profit Growth5 Y	-1.57%
Net Income	TWD -567.4M
Net Income Growth Years	0%
Pretax Margin	-5.94%
Profit Margin	-12.35%
Profit Per Employee	TWD -1.7M
ROA	-1.63
Roa5y	-0.58
ROCE	-3.34
ROE	-7.29
Roe5y	-2.8
ROIC	-3.61
Roic5y	-1.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.21%
Cagr15y	1.65%
Cagr1y	0.51%
Cagr20y	8.77%
Cagr3y	9.23%
Cagr5y	2.53%
Div CAGR10	-4.59%
Div CAGR3	-24.78%
Div CAGR5	-11.09%
EPS Growth Years	0
Revenue Growth	4.64x
Revenue Growth Q	5.62x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.96x
Revenue Growth5 Y	-3.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.39
Assets	TWD 12.2B
Cash	TWD 2.1B
Current Assets	TWD 4.3B
Current Liabilities	TWD 2.9B
Debt	TWD 3.3B
Debt Equity	TWD 0.44
Debt FCF	TWD -7
Equity	TWD 7.4B
Interest Coverage	-4.19
Liabilities	TWD 4.9B
Long Term Assets	TWD 7.9B
Long Term Liabilities	TWD 1.9B
Net Cash	TWD -1.2B
Net Cash By Market Cap	TWD -29.09
Net Debt Equity	TWD 0.16
Tangible Book Value	TWD 6.2B
Tangible Book Value Per Share	TWD 71.89
WACC	3.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	2.16
Net Working Capital	TWD 1.3B
Quick ratio	1.01
Working Capital	TWD 1.4B
Working Capital Turnover	TWD 4.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 4
Dividend Years	2
Dividend Yield	8.59%
Last Dividend	TWD 1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	24.37%
1Y total return	0.51%
200-day SMA	47.89
3Y total return	30.34%
50-day SMA	46.24
50-day SMA vs 200-day SMA	50under200
5Y total return	13.31%
All Time High	111
All Time High Change	-58.06%
All Time High Date	2013-09-09
All Time Low	6
All Time Low Change	675.32%
All Time Low Date	2004-08-09
ATR	0.69
Beta	0.15
Beta1y	0.1
Beta2y	0.32
Ch YTD	3.91
High	46.6
High52	58.9
High52 Date	2025-07-07
High52ch	-20.97%
Low	46.15
Low52	42.6
Low52 Date	2026-01-21
Low52ch	9.27%
Ma50ch	0.67%
Price vs 200-day SMA	-2.79%
RSI	48
RSI Monthly	50.22
RSI Weekly	49.61
Sharpe ratio	0.29x
Sortino ratio	0.7
Total Return	8.59%
Tr YTD	3.91
Tr15y	27.89%
Tr1m	-1.79%
Tr1w	-1.79%
Tr3m	3.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -310.5M
Operating margin	-6.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,454,549%
Net Borrowing	-949,202,000
Shares Insiders	14.47%
Shares Institutions	0.31%
Shares Out	86,747,119
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -466.5M
Average Volume	36,359.8x
Bv Per Share	72.48
CAPEX	TWD -173.7M
Ch10y	-4.22
Ch15y	-11.84
Ch1m	-1.79
Ch1w	-1.79
Ch1y	-1.27
Ch20y	243.4
Ch3m	3.91
Ch3y	25.47
Ch5y	2.42
Ch6m	-0.43
Change	-0.11%
Change From Open	0.11
Close	46.6
Days Gap	-0.21
Depreciation Amortization	155,459,000
Dollar Volume	3,949,907.2
Earnings Date	2026-05-12
EBIT	TWD -310.5M
EBITDA	TWD -155.1M
EPS	TWD -6.54
F Score	4
FCF	TWD -465.9M
FCF EV Yield	-7.42x
FCF Per Share	TWD -5.37
Financing CF	-483,304,000
Fiscal Year End	December
Founded	1,982
Income Tax	TWD 207.2M
Investing CF	1,294,746,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2010-07-28
Last Split Type	Forward
Ma150	46.29
Ma150ch	0.55%
Ma20	46.98
Ma20ch	-0.92%
Net CF	514,619,000
Next Earnings Date	2026-05-12
Open	46.5
Payment Date	2025-08-06
Position In Range	88.89
Ppne	3,857,453,000
Price Date	2026-05-08
Ptbv Ratio	0.65
Relative Volume	2.59x
Revenue	4,595,102,000x
SBC By Revenue	0.01x
Share Based Comp	640,000
Tax By Revenue	4.51x
Tr20y	437.15%
Tr6m	-0.43%
Volume	84,853
Z Score	1.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4120 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+8.6%

$4.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-11.1%

0 consecutive years of growth

Total shareholder yield

+8.6%

Dividend yield + buyback yield combined

Performance

TPEX/4120 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4120?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+14.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/4120 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.0

Neutral momentum band

Price vs 200-day MA

-2.8%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4120

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4120 stock rating?

tpex/4120 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4120 analysis?

The full report lives at /stocks/tpex/4120/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4120?

The latest report frames tpex/4120 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4120 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.